Cornerstone Planning Group LLC Royalty Pharma PLC Transaction History
Cornerstone Planning Group LLC
- $624 Billion
- Q3 2025
A detailed history of Cornerstone Planning Group LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 531 shares of RPRX stock, worth $20,793. This represents 0.01% of its overall portfolio holdings.
Number of Shares
531
Previous 125
324.8%
Holding current value
$20,793
Previous $4.74 Million
1117.62%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
527Shares Held
303MCall Options Held
1.46MPut Options Held
309K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...